Core Viewpoint - The company has released its 2025 semi-annual report, which includes financial data and the status of fundraising activities, ensuring compliance with regulatory requirements [1][4][11]. Company Overview - The company is identified as 中安科 (Zhong An Ke), with the stock code 600654 [1]. - The report emphasizes the importance of reviewing the full semi-annual report for a comprehensive understanding of the company's performance and future plans [1]. Financial Data - The company raised a total of approximately RMB 952.99 million through a non-public offering of 131,994,459 shares at an issue price of RMB 7.22 per share [11]. - After deducting issuance costs of about RMB 19.06 million, the net proceeds amounted to approximately RMB 933.94 million [11]. - As of June 30, 2025, the company had invested approximately RMB 902.66 million of the raised funds, with a remaining balance of RMB 59,951.80 [12]. Board Meeting - The 12th Board of Directors held its fifth meeting on August 29, 2025, with all nine directors present, and the meeting adhered to legal and procedural requirements [3][6]. - The board approved the semi-annual report and the special report on the use of raised funds, confirming that these documents had been reviewed by the audit committee prior to the meeting [4][7]. Fundraising Management - The company has established a management framework for the raised funds, ensuring compliance with relevant laws and regulations [13]. - A four-party supervision agreement was signed with banks to manage the raised funds, ensuring proper oversight [14]. Fund Usage - No funds were used to replace pre-invested capital in the first half of 2025, and there were no investments made with idle funds during this period [16][18]. - The company had previously approved the temporary use of RMB 37 million of idle funds to supplement working capital, but due to account freezes, the funds were not returned as scheduled [17][21]. Issues and Compliance - The company has been actively addressing issues related to the temporary use of idle funds and is exploring solutions to resolve historical problems and related litigation [21]. - The company asserts that all disclosed information regarding the use of raised funds is timely, truthful, accurate, and complete, with no violations of regulatory requirements [21].
中安科股份有限公司2025年半年度报告摘要